Acalnib 100 mg Capsule

Description

Acalnib 100 mg Capsule contains Acalabrutinib, a targeted anticancer medicine used to treat certain blood cancers. It helps slow cancer cell growth and disease progression under oncologist supervision.

Benefits

• Targets cancer-causing B-cell pathways

• Helps slow tumor growth and spread

• Can improve progression-free survival

• Convenient oral capsule formulation

• Well-established option in modern hematologic oncology

Indications and Usage

Acalnib 100 mg Capsule is indicated for the treatment of:

• Mantle Cell Lymphoma (MCL) in adults previously treated

• Chronic Lymphocytic Leukemia (CLL)

• Small Lymphocytic Lymphoma (SLL)

Treatment must be initiated and supervised by an experienced oncologist.

How it Works

Acalabrutinib selectively inhibits BTK (Bruton Tyrosine Kinase) — a key enzyme required for malignant B-cell growth. By blocking this pathway, it prevents cancer cells from multiplying, helping control disease progression.

Dosage & Administration

• Typical dose: 100 mg twice daily, or as prescribed

• Swallow capsule whole with water

• Take at the same times each day

• Do not crush, chew, or open capsules

• Do not skip or double doses

• Routine blood tests and clinical monitoring required

Use only under oncologist guidance.

Side Effects

Common side effects:

• Headache

• Fatigue

• Diarrhea

• Muscle or joint pain

• Bruising or bleeding

Serious side effects:

• Severe bleeding

• Serious infections

• Irregular heartbeat (atrial fibrillation)

• Secondary cancers

• Low blood cell counts

Seek medical attention if severe or persistent symptoms occur.

Warning and Precaution

• Not recommended during pregnancy or breastfeeding

• Use caution in patients with bleeding, heart, or liver disorders

• Avoid live vaccines during treatment

• Increased risk of infections — report fever immediately

• Inform doctor about blood thinners or other ongoing medications

• Stop treatment and seek help if allergic symptoms develop